Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 6:50 PM
Ignite Modification Date:
2025-12-25 @ 4:21 PM
NCT ID:
NCT00942357
Group ID:
EG000
Title:
Arm I (Cisplatin, Radiation Therapy, Paclitaxel, Carboplatin)
Description:
Patients receive cisplatin IV on days 1 and 29. Patients also undergo radiation therapy QD, 5 days a week, for 5-6 weeks. Some patients may then undergo brachytherapy over 2-3 weeks. Beginning within 8 weeks after completion of chemoradiotherapy, patients receive paclitaxel IV over 3 hours and carboplatin IV on day 1. Treatment repeats every 21 days for 4 courses in the absence of disease progression or unacceptable toxicity.
Carboplatin: Given IV
Cisplatin: Given IV
Internal Radiation Therapy: Undergo brachytherapy
Paclitaxel: Given IV
Quality-of-Life Assessment: Ancillary studies
Radiation Therapy: Undergo radiation therapy
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
78
Serious Number At Risk:
346
Other Number Affected:
346
Other Number At Risk:
346
Study:
NCT00942357
Results Section:
NCT00942357
Adverse Events Module:
NCT00942357